Del Rosario, Cresilda .

HRN: 28-57-17  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2026
CO-AMOXICLAV 625MG (TAB)
03/18/2026
03/25/2026
PO
1 Cap
TID
UTI
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Urinary Tract    Compliance to guidelines: